These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 9491473)

  • 1. [Percutaneous penetration of drugs--application in physical therapy].
    Clarys P; Barel A; Taeymans J
    Sportverletz Sportschaden; 1997 Dec; 11(4):XIX-XXIII. PubMed ID: 9491473
    [No Abstract]   [Full Text] [Related]  

  • 2. Influence of ointment formulation on skin erythema induced by nicotinate esters.
    Realdon N; Ragazzi E; Dal Zotto M; Ragazzi E
    Pharmazie; 1995 Sep; 50(9):603-6. PubMed ID: 7480096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparative pharmacokinetics of salicylic acids administered orally and topically on the skin].
    Gawrońska-Szklarz B; Górnik W; Kustroń B; Wójcicki J; Samochowiec L
    Pol Tyg Lek; 1983 Apr; 38(17):525-7. PubMed ID: 6634501
    [No Abstract]   [Full Text] [Related]  

  • 4. Enhancement of topical delivery of drugs via direct penetration by reducing blood flow rate in skin.
    Higaki K; Nakayama K; Suyama T; Amnuaikit C; Ogawara K; Kimura T
    Int J Pharm; 2005 Jan; 288(2):227-33. PubMed ID: 15620862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo microdialysis for the investigation of drug levels in the dermis and the effect of barrier perturbation on cutaneous drug penetration. Studies in hairless rats and human subjects.
    Benfeldt E
    Acta Derm Venereol Suppl (Stockh); 1999; 206():1-59. PubMed ID: 10605601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphatic transport of salicylates in dogs.
    Sudo LS; Almeida MG; Yasaka W; Garcia-Leme J
    Gen Pharmacol; 1989; 20(6):779-83. PubMed ID: 2591706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative tissue absorption of oral 14C-aspirin and topical triethanolamine 14C-salicylate in human and canine knee joints.
    Rabinowitz JL; Feldman ES; Weinberger A; Schumacher HR
    J Clin Pharmacol; 1982 Jan; 22(1):42-8. PubMed ID: 6977559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Percutaneous absorption of salicylic acid after repeated (14-day) in vivo administration to normal, acnegenic or aged human skin.
    Davis DA; Kraus AL; Thompson GA; Olerich M; Odio MR
    J Pharm Sci; 1997 Aug; 86(8):896-9. PubMed ID: 9269866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Percutaneous absorption of salicylates from some commercially available topical products containing methyl salicylate or salicylate salts in rats.
    Megwa SA; Benson HA; Roberts MS
    J Pharm Pharmacol; 1995 Nov; 47(11):891-6. PubMed ID: 8708981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Penetration rate and action. Percutaneous topical administration of NSAIDs].
    Schmidt G
    Pharm Unserer Zeit; 2002; 31(2):200-5. PubMed ID: 11977456
    [No Abstract]   [Full Text] [Related]  

  • 11. Ocular distribution of aspirin and salicylate following systematic administration of aspirin to rabbits.
    Valeri P; Romanelli L; De Paolis L; Martinelli B
    J Pharm Pharmacol; 1988 Nov; 40(11):823-4. PubMed ID: 2907571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lamellar Liquid Crystal Improves the Skin Retention of 3-O-Ethyl-Ascorbic Acid and Potassium 4-Methoxysalicylate In Vitro and In Vivo for Topical Preparation.
    Li Y; Dong C; Cun D; Liu J; Xiang R; Fang L
    AAPS PharmSciTech; 2016 Jun; 17(3):767-77. PubMed ID: 26349686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The effect of physical factors on the skin permeability of normal white rats and in the modelling of pathological processes].
    Tereshin SIu
    Vopr Kurortol Fizioter Lech Fiz Kult; 2000; (4):50-3. PubMed ID: 11008582
    [No Abstract]   [Full Text] [Related]  

  • 14. [Percutaneous absorption: topical and systemic treatments].
    Machet L; Baïcan A; Pelucio-Lopes C; Patat F; Vaillant L
    Ann Dermatol Venereol; 1997; 124(6-7):490-6. PubMed ID: 9739917
    [No Abstract]   [Full Text] [Related]  

  • 15. Dermal copper drugs: the copper bracelet and cu(II) salicylate complexes.
    Walker WR; Beveridge SJ; Whitehouse MW
    Agents Actions Suppl; 1981; 8():359-67. PubMed ID: 7008557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Study of toxicokinetics and cumulative properties of salicylic acid derivatives].
    Novikov SM; Mel'nikova NN; Andrusov VE; Semenovykh LN; Murkova MV
    Gig Sanit; 1992; (7-8):65-8. PubMed ID: 1468676
    [No Abstract]   [Full Text] [Related]  

  • 17. [Methods and models for percutaneous absorption studies of organophosphates].
    Boudry I; Trescos Y; Vallet V; Cruz C; Lallement G
    Pathol Biol (Paris); 2008 Jul; 56(5):292-9. PubMed ID: 18191343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical delivery of cosmetics and drugs. Molecular aspects of percutaneous absorption and delivery.
    Förster M; Bolzinger MA; Fessi H; Briançon S
    Eur J Dermatol; 2009; 19(4):309-23. PubMed ID: 19443302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Workshop report on in vivo percutaneous penetration/absorption. Washington D.C., May 1-3, 1989.
    Shah VP; Flynn GL; Guy RH; Maibach HI; Schaefer H; Skelly JP; Wester RC; Yacobi A
    Skin Pharmacol; 1991; 4(3):220-8. PubMed ID: 1685087
    [No Abstract]   [Full Text] [Related]  

  • 20. Is there tissue penetration after application of topical salicylate formulations?
    Cross SE; Anderson C; Thompson MJ; Roberts MS
    Lancet; 1997 Aug; 350(9078):636. PubMed ID: 9288049
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.